Study Examines Risk for ONJ in Cancer Patients Who Take Bone-Modifying Agents
An investigation by researchers at the University of Michigan Comprehensive Cancer Center in Ann Arbor examined the association between osteonecrosis of the jaw (ONJ) in cancer patients and the use of bone-modifying agents to reduce the…